Genmab(GMAB) - 2024 Q1 - Earnings Call Presentation
Genmab(GMAB)2024-05-03 00:38
Quarter End Results Period Ended March 31, 2024 Forward looking This presentation contains forward looking development, uncertainties related to the statements. The words “believe”, “expect”, outcome of clinical trials, slower than expected “anticipate”, “intend” and “plan” and similar rates of patient recruitment, unforeseen safety statement expressions identify forward looking statements. issues resulting from the administration of our All statements other than statements of historical products in patient ...